Skip to main content
A

Aizon

Aizon provides a cloud‑native, AI‑powered SaaS platform that consolidates manufacturing data into a GxP‑compliant lakehouse and delivers real‑time monitoring, predictive yield optimization, and automated batch review for pharmaceutical producers. The solution integrates with existing MES and LIMS systems to flag deviations, accelerate batch release, and support root‑cause analysis while maintaining audit‑ready data integrity.

San Francisco, United StatesFounded 20141595K+ followers
Updated 3 months ago

Funding

$20M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

NC
Funding rounds are not available yet.

Founders

Product

Problem

Pharmaceutical manufacturers operating under GxP regulations often struggle with low batch yields, frequent process deviations, and lengthy release cycles due to fragmented data sources and manual analysis. These inefficiencies increase cost of goods sold and expose organizations to compliance risk. Limited real‑time visibility into process parameters hampers proactive decision‑making.

Solution

Aizon delivers a cloud‑native, AI‑powered SaaS platform that unifies manufacturing data into an intelligent lakehouse and applies machine‑learning models to predict and prevent deviations. The suite includes Execute for automated batch execution, Unify for real‑time process monitoring, digital batch review, and batch‑to‑batch analytics, and Predict for multivariate yield optimization and root‑cause analysis. By contextualizing historical and streaming data, the platform generates actionable insights that enable operators to adjust parameters on the fly, accelerate batch release, and maintain FDA audit readiness. Integrated consulting services accelerate deployment, delivering measurable improvements within six weeks. All solutions are built to meet GxP data integrity and security standards, allowing seamless integration with existing MES and LIMS environments.

Target Audience

The primary customers are quality, production, and technology‑operations leaders at pharmaceutical manufacturers, CDMOs, and biotech firms seeking to improve batch yield, reduce deviations, and meet GxP compliance requirements.

Features

  • AI‑driven multivariate predictive models that forecast yield and flag potential deviations before they impact production
  • Real‑time process monitoring dashboard with streaming data ingestion from PLCs, SCADA, and LIMS systems
  • Intelligent lakehouse architecture that consolidates batch, equipment, and quality data for fast, contextualized analytics
  • Automated batch comparison analytics that surface variance drivers across historical runs and support digital batch review
  • Integrated root‑cause analysis tools that combine statistical RCA with machine‑learning insights for rapid deviation resolution
  • Role‑based access control and GxP‑compliant audit trails ensuring data integrity and regulatory compliance
  • Scalable SaaS deployment with RESTful APIs for seamless connectivity to existing enterprise systems
  • Optional consulting engagement that customizes data integration, hypothesis testing, and solution validation within a defined 6‑week timeline
This profile is AI-generated and may contain inaccuracies.